why choose us

Clinical Trials Search

Showing 9,550 of 132,366 result(s)
Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness

Status: NOT_YET_RECRUITING

Condition: Prostatic Neoplasm

Interventions: One-on-one meeting with a nutritionist to discuss and personalize dietary recommendations for patients with prostate cancer undergoing ADT.

Date: 2023-07-21

A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease

Status: Completed

Condition: Non-alcoholic Fatty Liver Disease

Interventions: BI 3006337

Date: 2023-07-21

Emotional Cognition: Establishing Constructs and Neural-Behavioral Mechanisms in Older Adults With Depression

Status: Completed

Condition: Major Depressive Disorder (MDD)

Interventions:

  1. Emotion processing:

    • Participants will be shown a series of faces that appear quickly and be asked to identify what emotion is sh

      Date: 2023-07-21

Describing Patient With DME, Their Patient Journey and Disease Progression

Status: ACTIVE_NOT_RECRUITING

Condition: Diabetic Macular Edema

Interventions:

Date: 2023-07-21

A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

Status: ACTIVE_NOT_RECRUITING

Condition: Prostatic Neoplasms, Castration-Resistant

Interventions: As provided in real-world setting

Date: 2023-07-21

Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery

Status: Completed

Condition: Obesity

Interventions: Topiramate is an anticonvulsant (antiepilepsy) drug.
IUPAC ID: 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate

Date: 2023-07-21

DailyDose Smart Snack Study for T1D on MDI

Status: COMPLETED

Condition: Type 1 Diabetes Mellitus With Hypoglycemia

Interventions: A decision support tool that predicts the likelihood of overnight low blood sugar based on current CGM and inputted exercise.
App will recommend

Date: 2023-07-21

A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected Pancreatic Ductal Adenocarcinoma

Status: Completed

Condition: Adenocarcinoma, Pancreatic Ductal

Interventions: Autogene cevumeran will be administered intravenously (IV) at a recommended dose at specified timepoints.

Date: 2023-07-21

A Culturally Adapted, Social Support-Based, Physical Activity Interventions for South Asian Indian Women in the United States

Status: Completed

Condition: Sedentary Behavior

Interventions: This will be delivered by a certified nurse coach, certified in holistic nursing who will provide 6 sessions of Zoom health coaching over 12 weeks to

Date: 2023-07-21